Huajun Wang

671 citations
23 papers · 470 indexed · h-index 13
Topics
Pulmonary Hypertension Research and Treatments (10 papers)Mesenchymal stem cell research (2 papers)Trace Elements in Health (2 papers)
Partner nations
ChinaHong Kong

In The Last Decade

Huajun Wang

23 papers receiving 464 citations

Peers

Huajun Wang
Comparison fields: 5 of 88
  • Pulmonary and Respiratory Medicine 167
  • Molecular Biology 162
  • Cardiology and Cardiovascular Medicine 88
  • Clinical Psychology 68
  • Cancer Research 57
Replace Juzhong Sun with:
Juzhong Sun United States
Mark Spears United Kingdom
Gao Yt China
C J Chen Taiwan
Michael J. Messino United States
Zhen Fu China
Margaret Sloan Canada
Brenton J. Baguley Australia
Helle C. Thiesson Denmark
Huajun Wang relative to Juzhong Sun United States Juzhong Sun's profile →
Citations per field
00.5×4.1×
Juzhong Sun · 1×
Citations per year

Countries citing papers authored by Huajun Wang

Since Specialization
Citations

This map shows the geographic impact of Huajun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huajun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huajun Wang more than expected).

Fields of papers citing papers by Huajun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huajun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huajun Wang. The network helps show where Huajun Wang may publish in the future.

Co-authorship network of co-authors of Huajun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Huajun Wang. A scholar is included among the top collaborators of Huajun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huajun Wang. Huajun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 11
4 61
5 20
6 16
7 71
8 42
9 25
10 17
11 25
12 2
13 46
14 24
15 2
16 4
17 7
18 7
19 39
20 3

About Huajun Wang

Huajun Wang is a scholar working on Aging, Business and International Management and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 470 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (10 papers), Mesenchymal stem cell research (2 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (167 citations), Otorhinolaryngology (22 citations) and Speech and Hearing (29 citations). Huajun Wang has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Liangdi Xie, Guili Lian, Li Luo, Tingjun Wang, Changsheng Xu, Jin Gong, Qingshan Geng, Ai Chen, Huan Ma and Jihui Zhang. Their work appears in journals such as Scientific Reports, Psychological Medicine and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026